TimeMon-Sat 9.00 AM - 6.00 PM
Paclitaxel (Protein-bound Particle) For Injectable Suspension

Paclitaxel (Protein-bound Particle) For Injectable Suspension

Product Details:

  • Indication Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer
  • Dosage Form Injectable Suspension
  • Salt Composition Paclitaxel (Protein-Bound Particle)
  • Feature Solvent-free, Albumin-bound formulation to improve delivery
  • Ingredients Paclitaxel (protein-bound), Human albumin
  • Application
  • Ph Level Approximately 7.08.0
  • Click to view more
X

Paclitaxel (Protein-bound Particle) For Injectable Suspension Price And Quantity

  • 100 Pack

Paclitaxel (Protein-bound Particle) For Injectable Suspension Product Specifications

  • Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer
  • AS PER INSTRUCTIONS
  • Paclitaxel (protein-bound), Human albumin
  • 24 Months
  • Approximately 7.08.0
  • White to off-white lyophilized powder
  • Solvent-free, Albumin-bound formulation to improve delivery
  • Injectable Suspension
  • Paclitaxel (Protein-Bound Particle)
  • Odorless

Paclitaxel (Protein-bound Particle) For Injectable Suspension Trade Information

  • AHEMDABAD, MUNDRA & MUMBAI
  • 1000 Pack Per Month
  • 2 Week
  • No
  • SINGLE USE VIAL
  • AS PER AVAILABILITY

Product Description

PRODUCT NAME:PACLITAXEL (PROTEIN-BOUND PARTICLE) FOR INJECTABLE SUSPENSION

GENERIC NAME: PACLITAXEL (PROTEIN-BOUND PARTICLE) FOR INJECTABLE SUSPENSION

MANUFACTURER: OCEAN

PACKING: FOR SINGLE VIAL


USES: PACLITAXEL Injection is an anti-cancer medication used for the treatment of breast cancer, pancreatic cancer, and non-small cell lung cancer. It is given as an intravenous (IV) injection into your vein, usually over 1 hour and every three weeks.




Advanced Albumin-Bound Chemotherapy

Paclitaxel (Protein-Bound Particle) utilizes human albumin to enhance drug delivery, offering superior targeting of tumor cells with minimized solvent-related toxicity. This innovative formulation is designed for intravenous infusion and is suitable for patients undergoing treatment for multiple cancers including breast, lung, and pancreatic malignancies.


Safe and Convenient Administration

Packaged as a single-use vial containing 100 mg of lyophilized powder, Paclitaxel (Protein-Bound Particle) can be reconstituted and administered using standard IV solvent sets. Its solvent-free composition reduces the risk of hypersensitivity reactions typically associated with conventional chemotherapy agents.

FAQs of PACLITAXEL (PROTEIN-BOUND PARTICLE) FOR INJECTABLE SUSPENSION:


Q: How is Paclitaxel (Protein-Bound Particle) For Injectable Suspension administered?

A: Paclitaxel (Protein-Bound Particle) For Injectable Suspension is administered intravenously as an infusion, using standard IV solvent sets, typically under the supervision of oncology specialists in a clinical setting.

Q: What are the main indications for using this injectable suspension?

A: This medication is indicated for the treatment of breast cancer, non-small cell lung cancer, and pancreatic cancer. It is commonly used as part of chemotherapy protocols in oncology practices.

Q: When should Paclitaxel (Protein-Bound Particle) therapy be initiated?

A: Initiation depends on oncologist assessment and diagnosis. Therapy typically starts when a patient is diagnosed with an appropriate cancer type and oral therapies or conventional medications are not suitable, or when albumin-bound formulations are warranted for safety.

Q: Where can I obtain Paclitaxel (Protein-Bound Particle) For Injectable Suspension?

A: The product is available by prescription through licensed medical facilities, hospitals, and specialty pharmacies. Export and bulk orders can be arranged with the manufacturer in India according to minimum quantity requirements.

Q: What is the process for preparing and storing this injectable suspension?

A: Paclitaxel (Protein-Bound Particle) should be reconstituted as per the instructions provided by the manufacturer and healthcare provider. It must be stored according to specific guidelines and is intended for single use only, with a shelf life of 24 months.

Q: How does the albumin-bound formulation benefit patients?

A: Albumin-binding improves solubility and delivery of Paclitaxel, allowing the medication to be administered without additional solvents, which reduces the risk of adverse reactions and enhances therapeutic efficacy against cancer cells.

Q: What safety features and compliance certifications does this product offer?

A: The product is USP compliant, odorless, solvent-free, and accompanied by a Material Safety Data Sheet (MSDS). Its safety profile is elevated by avoiding solvent-related toxicities and meeting international pharmaceutical standards.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'ANTI CANCER INJECTION' category



Back to top